Summary • Cartesian Therapeutics (RNAC) shares rose 6.9% in pre-market trading, reaching $7.18. • Director Timothy C. Barabe purchased 30,000 shares at $6.86, indicating possible insider confidence. • ...
Moving from 3-axis to 5-axis machining? Yeah, it’s a big jump. And honestly, the hardest part isn’t learning new G-codes or figuring out your CAM software—it’s wrapping your head around how these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback